1 |
IL17A
💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Secukinumab
Secukinumab
💬
|
Secukinumab
| 8件: 13 13, 37, 41, 46, 107, 160, 269, 271 💬
|
2 |
IL17A
💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Ixekizumab
Ixekizumab
💬
|
Ixekizumab
| 8件: 36 36, 37, 46, 107, 160, 162, 269, 271 💬
|
3 |
IL17A
💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Tibulizumab
Tibulizumab
💬
|
Tibulizumab
| 1件: 53 53 💬
|
4 |
IL17A
💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Bimekizumab
Bimekizumab
💬
|
Bimekizumab
| 3件: 46 46, 97, 271 💬
|